Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis

Journal of Dermatology

Volumn 38, Issue 10, 2011, Pages 966-972

  Shintani, Yoichi ^a   Kaneko, Natumi ^a   Furuhashi, Takuya ^a   Saito, Chiyo ^a   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

cyclosporin; fixed dose; low dosage; psoriasis; safety

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; RETINOID DERIVATIVE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; MALE; MICROEMULSION; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ADULT; CYCLOSPORINE; DRUG MONITORING; DRUG TOXICITY; EMULSIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 80053277173     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01228.x     Document Type: Article

References (12)

1. Berth-Jones J, Henderson CA, Munro CS, et al. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study. Br J Dermatol 1997; 136: 527-530. (Pubitemid 27160325)
2. Ho VC, Griffiths CE, Berth-Jones J, et al. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. J Am Acad Dermatol 2001; 44: 643-651. (Pubitemid 32249523)
3. Salek MS, Finlay AY, Lewis JJ, Sumner MI,. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res 2004; 13: 91-95. (Pubitemid 38315224)
4. Abe M, Ishibuchi H, Syuto T, Sogabe Y, Yokoyama Y, Ishikawa O,. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris. J Dermatol 2007; 34: 290-293. (Pubitemid 46535948)
5. Hashizume H, Ito T, Yagi H, et al. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris. J Dermatol 2007; 34: 430-434. (Pubitemid 46956586)
6. Warren RB, Griffiths CE,. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol 2008; 26: 438-447.
7. Chaidemenos GC, Mourellou O, Avgoustinaki N, Papakonstantinou M, Karakatsanis G, Katsambas A,. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2007; 21: 1203-1208. (Pubitemid 47423408)
8. Nakagawa H, Aiba S, Asahina I, et al. A consensus conference report on psoriasis therapy with cyclosporine MEPC. Jpn J Dermatol 2004; 114: 1093-1105.
9. Mehlis SL, Gordon KB,. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003; 49: S44-S50. (Pubitemid 36951246)
10. Takahashi H, Tsuji H, Iizuka H,. Application of 3 mg/kg of Cyclosporine A (NEORAL®) once dairy is effective for severe and moderate psoriasis. West Jpn Dermatol (Japanese) 2009; 71: 63-69.
11. Umezawa Y, Ozawa A,. Cyclosporin therapy based on the TDM (therapeutic drug monitoring) for psoriasis. Clin Dermatol (Japanese) 2004; 58: S96-S100.
12. Umezawa Y, Mabuchi T, Ozawa A,. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis. Int J Dermatol 2007; 46: 880-882. (Pubitemid 47162797)